Scholar Response
Response Fields
| Field | Type | Description | Example |
|---|---|---|---|
| lens_id | String | Unique lens identifier | 100-004-910-081-14X |
| created | Date | Record created date | 2016-08-01T00:00:00+00:00 |
| publication_type | String (Publication Types) | Publication Type | journal article |
| publication_supplementary_type | Array of String | Supplementary publication type | ["review"] |
| authors | Array of Author | Authors | |
| title | String | Title of the scholarly work | Malaria |
| external_ids | Array of Ids | The external identifier(s) for a scholarly work (DOI, PubMed ID, PubMed Central ID, Microsoft Academic ID or CORE) | |
| start_page | String | Start page | 893 |
| end_page | String | End page | 916 |
| volume | String | Volume | 32 |
| issue | String | Issue | 4 |
| languages | Array of String | Languages | ["en"] |
| references | List of References | References | |
| references_count | Integer | The number of works in the reference list of a scholarly work | 22 |
| references_resolved_count | Integer | The number of works in the reference list of a scholarly work that have been resolved to a scholarly work Lens Id | 21 |
| scholarly_citations | List of Lens Ids | Scholarly Citations | ["091-020-924-584-261", "159-770-478-635-994", ...] |
| scholarly_citations_count | Integer | The number of scholarly works that cite this scholarly work | 3 |
| patent_citations | Array of Patent Citation | Referenced by patents | |
| patent_citations_count | Integer | Number of patent citations | 10 |
| chemicals | List of Chemical | Chemicals | |
| clinical_trials | List of Clinical Trial | Clinical Trials | |
| fields_of_study | List of String | Fields Of Study | ["Immunology", "Malaria"] |
| source_urls | List of Source URL | Source Urls | |
| abstract | String | Scholarly work abstract text | |
| date_published | Date | Date of publication | 2009-05-22 |
| date_published_parts | Array of Integer | Consist of year, month and day | [1974, 1, 6] |
| year_published | Integer | Year of publication | 1986 |
| conference | Conference | The conference instance or edition | |
| author_count | Integer | Number of Authors | 4 |
| open_access | Open Access | ||
| source | Source | Source publication in which the scholarly work appears | |
| keywords | Array of String | Keywords | |
| mesh_terms | Array of MeSH Term | MeSH term | |
| funding | Array of Funding | Funding |
Patent Citation
| Field | Type | Description | Example |
|---|---|---|---|
| lens_id | String | Unique lens identifier | 141-171-521-309-804 |
Author
| Field | Type | Description | Example |
|---|---|---|---|
| collective_name | String | Author Collective Name | |
| first_name | String | The author’s first name | Alexander |
| last_name | String | The author’s last name | Kupco |
| initials | String | Author Initials | A |
| affiliations | Array of Affiliation | The institution/affiliations associated with Author. | |
| ids | Array of Ids | Author’s MAG, ORCID identifiers | [{"type": "magid", "value": "1234567890"}] |
Affiliation
| Field | Type | Description | Example |
|---|---|---|---|
| name | String | The institution associated with the author affiliations. | Stony Brook University |
| name_original | String | The author’s original affiliation including the institution name and address. | School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts USA |
| grid_id | String | Affiliation grid id. NB This field is deprecated, please use the ids field instead. | grid.9018.0 |
| country_code | String | Comma separated country codes | DE |
| ids | Array of Ids | The external institution identifiers associated with the author’s affiliation |
References
| Field | Type | Description | Example |
|---|---|---|---|
| lens_id | String | Unique lens identifier | 041-778-570-427-167 |
| text | String | The the original text string in the references | Haddaway, N. R. & Verhoeven, J. T. Ecol. Evol. 5, 4451–4454 (2015). |
Open Access
| Field | Type | Description | Example |
|---|---|---|---|
| license | String | The Open Access license type | cc-by |
| colour | String | The Open Access colour category | gold |
| locations | [Open Access Location] | The Open Access Locations |
Source
| Field | Type | Description | Example |
|---|---|---|---|
| title | String | The name of source publication in which the scholarly work appears | Journal name, Book title, Confernce proceedings |
| type | String | Source Type | Journal |
| publisher | String | The publisher of the source publication | W.B. Saunders Ltd |
| issn | Array of Object | ISSN | [{"value": "10797114"}] |
| country | String | The publisher’s country | United Kingdom |
| asjc_codes | String | The All Science Journal Classification (ASJC) code | 2735 |
| asjc_subjects | String | Subject is derived from journals descriptions in Crossref metadata based on the Science Journal Classification Codes | Pediatrics |
Mesh Term
| Field | Type | Description | Example |
|---|---|---|---|
| mesh_id | String | MeSH term unique identifier. MeSH terms are the National Library of Medicine’s controlled vocabulary or subject heading list. | D000293 |
| mesh_heading | String | MeSH terms are the National Library of Medicine’s controlled vocabulary or medical subject headings assigned to PubMed entries. NB MeSH Headings are case sensitive. | Adolescent |
| qualifier_id | String | Mesh Term Qualifier ID | Q000032 |
| qualifier_name | String | Mesh Term Qualifier Name | analysis |
ISSN
| Field | Type | Description | Example |
|---|---|---|---|
| value | String | The International Standard Serial Number | 10797114 |
| type | String | ISSN type | print, electronic |
Funding
| Field | Type | Description | Example |
|---|---|---|---|
| org | String | Name of the funding organisation | NIDCR NIH HHS |
| funding_id | String | The funding organisation’s project identifier | U01 DE018902 |
| country | String | The country of the funding body | United States |
Conference
| Field | Type | Description | Example |
|---|---|---|---|
| name | String | Conference Name | International Electron Devices Meeting |
| instance | String | Conference Instance Name | CHI 1985 |
| location | String | The location of the conference | Lihue, Kauai, HA, USA |
Chemical
| Field | Type | Description | Example |
|---|---|---|---|
| mesh_id | String | MeSH term id | D000293 |
| registry_number | String | Chemical registration number | 5Q7ZVV76EI |
| substance_name | String | Substance name | Antimalarials |
Clinical Trial
| Field | Type | Description | Example |
|---|---|---|---|
| id | String | Identifier | nct00105716 |
| registry | String | Clinical Trial Registry | 10.18810/clinical-trials-gov |
Source URL
| Field | Type | Description | Example |
|---|---|---|---|
| type | String | Source URL Type | html, pdf, unknown |
| url | String | URL String | http://cds.cern.ch/record/2291692 |
Ids
| Field | Type | Description | Example |
|---|---|---|---|
| type | String | The type/s of external identifiers for the scholarly work, author, institution, etc. | doi, pmid, magid, orcid, grid, ror, etc. |
| value | String | The external identifier(s) for the scholarly work, author, institution, etc. | 10.1016/s0031-3955(16)34861-1, 0000-0003-3902-2234, grid.425957.8, 056x7d368, etc. |
Open Access Location
Field | Type | Description | Example
——- |:—————:|——————-|———
landing_page_urls | Array of String | Landing page urls | ["https://europepmc.org/articles/pmc5024789"]
pdf_urls | Array of String | PDF urls | ["http://www.ejcancer.com/article/S0959804915004505/pdf"]
Enums
Publication Types
journal article, letter, editorial, news, book, book chapter, conference proceedings article, conference proceedings, dataset, journal, journal issue, journal volume, report, standard, dissertation, clinical trial, clinical study, libguide, reference entry, working paper, component, review, preprint, other, unknown
Sample API Response
Request:
{
"query":{
"match":{"lens_id":"086-713-276-176-892"}
}
}
Response:
{
"total": 1,
"max_score": 19.05009,
"data": [
{
"lens_id": "086-713-276-176-892",
"title": "A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer",
"publication_type": "journal article",
"year_published": 2015,
"date_published": "2015-06-13T00:00:00.000000+00:00",
"date_published_parts": [
2015,
6,
13
],
"created": "2018-05-12T02:39:28.395000+00:00",
"external_ids": [
{
"type": "coreid",
"value": "82196673"
},
{
"type": "pmid",
"value": "26082390"
},
{
"type": "doi",
"value": "10.1016/j.ejca.2015.05.019"
},
{
"type": "pmcid",
"value": "pmc5024789"
},
{
"type": "magid",
"value": "2113210954"
}
],
"patent_citations": [
{
"lens_id": "122-064-734-901-067"
}
],
"patent_citations_count": 1,
"open_access": {
"locations": {
"landing_page_urls": [
"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024789/",
"https://doi.org/10.1016/j.ejca.2015.05.019",
"https://europepmc.org/articles/pmc5024789",
"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024789"
],
"pdf_urls": [
"http://www.ejcancer.com/article/S0959804915004505/pdf",
"https://europepmc.org/articles/pmc5024789?pdf=render"
]
},
"license": "cc-by-nc-nd",
"colour": "hybrid"
},
"authors": [
{
"first_name": "Maha",
"last_name": "Hussain",
"initials": "M",
"ids": [
{
"type": "magid",
"value": "2105158973"
}
],
"affiliations": [
{
"name": "University of Michigan",
"name_original": "University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States;",
"ids": [
{
"type": "magid",
"value": "27837315"
},
{
"type": "grid",
"value": "grid.214458.e"
},
{
"type": "isni",
"value": "0000000419367347"
},
{
"type": "fundref",
"value": "100007270"
},
{
"type": "ror",
"value": "00jmfr291"
}
],
"grid_id": "grid.214458.e",
"country_code": "US"
}
]
},
{
"first_name": "Dana E.",
"last_name": "Rathkopf",
"initials": "DE",
"ids": [
{
"type": "orcid",
"value": "0000-0002-4503-7582"
},
{
"type": "magid",
"value": "722834404"
}
],
"affiliations": [
{
"name": "Memorial Sloan Kettering Cancer Center",
"name_original": "Memorial Sloan Kettering New York NY United States",
"ids": [
{
"type": "magid",
"value": "1334819555"
},
{
"type": "grid",
"value": "grid.51462.34"
},
{
"type": "ror",
"value": "02yrq0923"
}
],
"grid_id": "grid.51462.34",
"country_code": "US"
}
]
},
{
"first_name": "Glenn",
"last_name": "Liu",
"initials": "G",
"ids": [
{
"type": "magid",
"value": "2133546628"
}
],
"affiliations": [
{
"name": "University of Wisconsin-Madison",
"name_original": "University of Wisconsin, Carbone Cancer Center, Madison, WI, United States.",
"ids": [
{
"type": "magid",
"value": "135310074"
},
{
"type": "grid",
"value": "grid.14003.36"
},
{
"type": "fundref",
"value": "100007015"
},
{
"type": "wikidata",
"value": "q838330"
},
{
"type": "ror",
"value": "01y2jtd41"
}
],
"grid_id": "grid.14003.36",
"country_code": "US"
}
]
},
{
"first_name": "Andrew J.",
"last_name": "Armstrong",
"initials": "AJ",
"ids": [
{
"type": "magid",
"value": "2172156363"
}
],
"affiliations": [
{
"name": "Duke University",
"name_original": "Duke Cancer Institute and Duke Prostate Center, Duke University, Durham, NC, United States",
"ids": [
{
"type": "magid",
"value": "170897317"
},
{
"type": "grid",
"value": "grid.26009.3d"
},
{
"type": "fundref",
"value": "100006510"
},
{
"type": "wikidata",
"value": "q168751"
},
{
"type": "ror",
"value": "00py81415"
}
],
"grid_id": "grid.26009.3d",
"country_code": "US"
}
]
},
{
"first_name": "Kevin",
"last_name": "Kelly",
"initials": "K",
"ids": [
{
"type": "magid",
"value": "2097407452"
}
],
"affiliations": [
{
"name": "Thomas Jefferson University",
"name_original": "Thomas Jefferson Univ., Philadelphia, PA (United States)",
"ids": [
{
"type": "magid",
"value": "149251103"
},
{
"type": "grid",
"value": "grid.265008.9"
},
{
"type": "ror",
"value": "00ysqcn41"
}
],
"grid_id": "grid.265008.9",
"country_code": "US"
}
]
},
{
"first_name": "Anna C.",
"last_name": "Ferrari",
"initials": "AC",
"ids": [
{
"type": "magid",
"value": "2312728207"
}
],
"affiliations": [
{
"name": "New York University",
"name_original": "New York University Clinical Cancer Center, New York, NY, United States.",
"ids": [
{
"type": "magid",
"value": "57206974"
},
{
"type": "grid",
"value": "grid.137628.9"
},
{
"type": "fundref",
"value": "100006732"
},
{
"type": "wikidata",
"value": "q49210"
},
{
"type": "ror",
"value": "0190ak572"
}
],
"grid_id": "grid.137628.9",
"country_code": "US"
}
]
},
{
"first_name": "John D.",
"last_name": "Hainsworth",
"initials": "JD",
"ids": [
{
"type": "magid",
"value": "2145549068"
}
],
"affiliations": [
{
"name": "Sarah Cannon Research Institute",
"name_original": "Sarah Cannon Research Institute, Nashville, TN, United States",
"ids": [
{
"type": "magid",
"value": "172427033"
},
{
"type": "grid",
"value": "grid.477834.b"
},
{
"type": "wikidata",
"value": "q30270369"
},
{
"type": "ror",
"value": "03cp5cj42"
}
],
"grid_id": "grid.477834.b",
"country_code": "GB"
}
]
},
{
"first_name": "Adarsh",
"last_name": "Joshi",
"initials": "A",
"ids": [
{
"type": "magid",
"value": "2097035297"
}
],
"affiliations": [
{
"name": "Eli Lilly and Company",
"name_original": "Eli Lilly and Company, Bridgewater, NJ, United States.",
"ids": [
{
"type": "magid",
"value": "168537998"
},
{
"type": "grid",
"value": "grid.417540.3"
},
{
"type": "fundref",
"value": "100004312"
},
{
"type": "ror",
"value": "01qat3289"
}
],
"grid_id": "grid.417540.3",
"country_code": "US"
}
]
},
{
"first_name": "Rebecca R.",
"last_name": "Hozak",
"initials": "RR",
"ids": [
{
"type": "magid",
"value": "2182553763"
}
],
"affiliations": [
{
"name": "Eli Lilly and Company",
"name_original": "Eli Lilly and Company, Indianapolis, IN (United States)",
"ids": [
{
"type": "magid",
"value": "168537998"
},
{
"type": "grid",
"value": "grid.417540.3"
},
{
"type": "fundref",
"value": "100004312"
},
{
"type": "ror",
"value": "01qat3289"
}
],
"grid_id": "grid.417540.3",
"country_code": "US"
}
]
},
{
"first_name": "Ling",
"last_name": "Yang",
"initials": "L",
"ids": [
{
"type": "magid",
"value": "2250633597"
}
],
"affiliations": [
{
"name": "Eli Lilly and Company",
"name_original": "Eli Lilly and Company, Bridgewater, NJ, United States.",
"ids": [
{
"type": "magid",
"value": "168537998"
},
{
"type": "grid",
"value": "grid.417540.3"
},
{
"type": "fundref",
"value": "100004312"
},
{
"type": "ror",
"value": "01qat3289"
}
],
"grid_id": "grid.417540.3",
"country_code": "US"
}
]
},
{
"first_name": "Jonathan D.",
"last_name": "Schwartz",
"initials": "JD",
"ids": [
{
"type": "magid",
"value": "2155041711"
}
],
"affiliations": [
{
"name": "Eli Lilly and Company",
"name_original": "Eli Lilly and Company, Bridgewater, NJ, United States.",
"ids": [
{
"type": "magid",
"value": "168537998"
},
{
"type": "grid",
"value": "grid.417540.3"
},
{
"type": "fundref",
"value": "100004312"
},
{
"type": "ror",
"value": "01qat3289"
}
],
"grid_id": "grid.417540.3",
"country_code": "US"
}
]
},
{
"first_name": "Celestia S.",
"last_name": "Higano",
"initials": "CS",
"ids": [
{
"type": "magid",
"value": "2560077320"
}
],
"affiliations": [
{
"name": "Fred Hutchinson Cancer Research Center",
"name_original": "University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, United States",
"ids": [
{
"type": "grid",
"value": "grid.270240.3"
},
{
"type": "ror",
"value": "007ps6h72"
}
],
"grid_id": "grid.270240.3",
"country_code": "US"
},
{
"name": "University of Washington",
"name_original": "University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, United States",
"ids": [
{
"type": "fundref",
"value": "100007812"
},
{
"type": "grid",
"value": "grid.34477.33"
},
{
"type": "ror",
"value": "00cvxb145"
}
],
"grid_id": "grid.34477.33",
"country_code": "US"
}
]
}
],
"source": {
"title": "European journal of cancer (Oxford, England : 1990)",
"type": "Journal",
"publisher": "Elsevier Limited",
"issn": [
{
"type": "unknown",
"value": "18790852"
},
{
"type": "print",
"value": "09598049"
}
],
"country": "United Kingdom",
"asjc_codes": [
"1306",
"2730"
],
"asjc_subjects": [
"Cancer Research",
"Oncology"
]
},
"fields_of_study": [
"Internal medicine",
"Oncology",
"Cixutumumab",
"Prednisone",
"Ramucirumab",
"Prostate cancer",
"Mitoxantrone",
"Docetaxel",
"Regimen",
"Phases of clinical research",
"Medicine"
],
"keywords": [
"Cixutumumab",
"Mitoxantrone",
"Prednisone",
"Prostate cancer",
"Ramucirumab"
],
"publication_supplementary_type": [
"clinical trial, phase ii",
"multicenter study",
"randomized controlled trial",
"research support, non-u.s. gov't"
],
"volume": "51",
"issue": "13",
"languages": [
"en"
],
"references": [
{
"lens_id": "003-415-704-045-340",
"text": "Wilke . Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial, Lancet Oncol. 2014; 15 1224."
},
{
"lens_id": "006-027-163-131-418",
"text": "Pandini . Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells, Cancer Res. 2005; 65 1849."
},
{
"lens_id": "010-839-632-959-305",
"text": "Spratlin . Ramucirumab (IMC-1121B): monoclonal antibody inhibition of vascular endothelial growth factor receptor-2, Curr Oncol Rep. 2011; 13 97."
},
{
"lens_id": "013-690-046-069-453",
"text": "Strohmeyer . Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer, Prostate. 2000; 45 216."
},
{
"lens_id": "015-449-984-502-884",
"text": "Int J Oncol. 2006 Mar;28(3):723-30"
},
{
"lens_id": "015-767-931-570-158",
"text": "Fuchs . Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial, Lancet. 2014; 383 31."
},
{
"lens_id": "018-245-327-947-052"
},
{
"lens_id": "020-963-415-260-304",
"text": "Wu . Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors, Clin Cancer Res. 2006; 12 (20 Pt 1) 6153."
},
{
"lens_id": "026-332-934-265-841",
"text": "Rubin . Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis, Prostate. 2004; 58 41."
},
{
"lens_id": "028-101-820-366-93X",
"text": "Garon . Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial, Lancet. 2014; 384 665."
},
{
"lens_id": "032-523-762-689-478",
"text": "Cancer Res. 2001 Mar 15;61(6):2533-6"
},
{
"lens_id": "037-117-740-052-570",
"text": "Doll . Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate, Prostate. 2001; 49 293."
},
{
"lens_id": "038-557-040-762-884",
"text": "Kawada . Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer, Cancer Res. 2006; 66 4419."
},
{
"lens_id": "040-239-601-782-040",
"text": "Burfeind . Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo, Proc Natl Acad Sci USA. 1996; 93 7263."
},
{
"lens_id": "042-246-996-698-043",
"text": "Bähr . The IGF-1 receptor and its contributions to metastatic tumor growth-novel approaches to the inhibition of IGF-1R function, Growth Factors. 2005; 23 1."
},
{
"lens_id": "043-024-349-674-734"
},
{
"lens_id": "043-201-312-439-671",
"text": "Clin Cancer Res. 2002 Aug;8(8):2714-24"
},
{
"lens_id": "043-546-849-370-25X",
"text": "Khandwala . The effects of insulin-like growth factors on tumorigenesis and neoplastic growth, Endocr Rev. 2000; 21 215."
},
{
"lens_id": "046-041-414-632-674",
"text": "Rowinsky . Blockade of insulin-like growth factor type-1 receptor with cixutumumab (IMC-A12): a novel approach to treatment for multiple cancers, Curr Drug Targets. 2011; 12 2016."
},
{
"lens_id": "046-648-350-541-685",
"text": "Sternberg . Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial, J Clin Oncol. 2009; 27 5431."
},
{
"lens_id": "046-852-526-558-260",
"text": "Tannock . Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer, N Engl J Med. 2004; 351 1502."
},
{
"lens_id": "054-808-246-993-497",
"text": "Scher . Design and end points of phase 2 trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group (PCWG2), J Clin Oncol. 2008; 26 1148."
},
{
"lens_id": "059-727-763-246-876",
"text": "Alva . The changing natural history of metastatic prostate cancer, Cancer J. 2013; 19 19."
},
{
"lens_id": "065-982-455-260-233",
"text": "Tannock . Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points, J Clin Oncol. 1996; 14 1756."
},
{
"lens_id": "069-612-901-254-771"
},
{
"lens_id": "070-794-057-102-152",
"text": "Spratlin . Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2, J Clin Oncol. 2010; 28 780."
},
{
"lens_id": "083-233-359-584-62X",
"text": "Hwang . Angiogenesis inhibitors in the treatment of prostate cancer, J Hematol Oncol. 2010; 3 26."
},
{
"lens_id": "087-375-055-670-659",
"text": "Blum . Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimics, J Biol Chem. 2003; 278 40442."
},
{
"lens_id": "087-458-139-690-01X",
"text": "de Bono . Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial, Lancet. 2010; 376 1147."
},
{
"lens_id": "090-234-280-758-859",
"text": "Yu . SWOG S0925: a randomized phase II study of androgen deprivation combined with cixutumumab versus androgen deprivation alone in patients with new metastatic hormone-sensitive prostate cancer, J Clin Oncol. 2015; 33 1601."
},
{
"lens_id": "094-489-992-059-749",
"text": "Petrylak . Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer, N Engl J Med. 2004; 351 1513."
},
{
"lens_id": "096-654-301-744-608",
"text": "Wu . In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors, Clin Cancer Res. 2005; 11 3065."
},
{
"lens_id": "101-625-667-760-940",
"text": "Clin Cancer Res. 2000 May;6(5):1882-90"
},
{
"lens_id": "113-073-836-369-700",
"text": "Cancer Res. 2003 Dec 15;63(24):8912-21"
},
{
"lens_id": "128-335-721-572-401"
},
{
"lens_id": "155-152-241-876-905",
"text": "Mauro . Role of the IGF-I receptor in the regulation of cell–cell adhesion: implications in cancer development and progression, J Cell Physiol. 2003; 194 108."
}
],
"mesh_terms": [
{
"mesh_heading": "Adenocarcinoma",
"qualifier_name": "drug therapy",
"mesh_id": "D000230",
"qualifier_id": "Q000188"
},
{
"mesh_heading": "Adolescent",
"mesh_id": "D000293"
},
{
"mesh_heading": "Adult",
"mesh_id": "D000328"
},
{
"mesh_heading": "Aged",
"mesh_id": "D000368"
},
{
"mesh_heading": "Antibodies, Monoclonal",
"qualifier_name": "administration & dosage",
"mesh_id": "D000911",
"qualifier_id": "Q000008"
},
{
"mesh_heading": "Antibodies, Monoclonal, Humanized",
"mesh_id": "D061067"
},
{
"mesh_heading": "Antineoplastic Combined Chemotherapy Protocols",
"qualifier_name": "adverse effects",
"mesh_id": "D000971",
"qualifier_id": "Q000009"
},
{
"mesh_heading": "Disease Progression",
"mesh_id": "D018450"
},
{
"mesh_heading": "Disease-Free Survival",
"mesh_id": "D018572"
},
{
"mesh_heading": "Docetaxel",
"mesh_id": "D000077143"
},
{
"mesh_heading": "Humans",
"mesh_id": "D006801"
},
{
"mesh_heading": "Kaplan-Meier Estimate",
"mesh_id": "D053208"
},
{
"mesh_heading": "Male",
"mesh_id": "D008297"
},
{
"mesh_heading": "Middle Aged",
"mesh_id": "D008875"
},
{
"mesh_heading": "Mitoxantrone",
"qualifier_name": "administration & dosage",
"mesh_id": "D008942",
"qualifier_id": "Q000008"
},
{
"mesh_heading": "Prednisone",
"qualifier_name": "administration & dosage",
"mesh_id": "D011241",
"qualifier_id": "Q000008"
},
{
"mesh_heading": "Proportional Hazards Models",
"mesh_id": "D016016"
},
{
"mesh_heading": "Prostatic Neoplasms, Castration-Resistant",
"qualifier_name": "drug therapy",
"mesh_id": "D064129",
"qualifier_id": "Q000188"
},
{
"mesh_heading": "Taxoids",
"qualifier_name": "therapeutic use",
"mesh_id": "D043823",
"qualifier_id": "Q000627"
},
{
"mesh_heading": "Time Factors",
"mesh_id": "D013997"
},
{
"mesh_heading": "Treatment Outcome",
"mesh_id": "D016896"
},
{
"mesh_heading": "United States",
"mesh_id": "D014481"
},
{
"mesh_heading": "Young Adult",
"mesh_id": "D055815"
},
{
"mesh_heading": "Ramucirumab",
"mesh_id": "D000096662"
}
],
"chemicals": [
{
"substance_name": "Antibodies, Monoclonal",
"registry_number": "0",
"mesh_id": "D000911"
},
{
"substance_name": "Antibodies, Monoclonal, Humanized",
"registry_number": "0",
"mesh_id": "D061067"
},
{
"substance_name": "Taxoids",
"registry_number": "0",
"mesh_id": "D043823"
},
{
"substance_name": "Docetaxel",
"registry_number": "15H5577CQD",
"mesh_id": "D000077143"
},
{
"substance_name": "cixutumumab",
"registry_number": "2285XW22DR",
"mesh_id": "C557414"
},
{
"substance_name": "Mitoxantrone",
"registry_number": "BZ114NVM5P",
"mesh_id": "D008942"
},
{
"substance_name": "Prednisone",
"registry_number": "VB0R961HZT",
"mesh_id": "D011241"
}
],
"clinical_trials": [
{
"id": "nct00683475",
"registry": "10.18810/clinical-trials-gov"
}
],
"funding": [
{
"org": "NCI NIH HHS",
"funding_id": "P30 CA008748",
"country": "United States"
}
],
"source_urls": [
{
"type": "html",
"url": "https://www.scholars.northwestern.edu/en/publications/a-randomised-non-comparative-phase-ii-trial-of-cixutumumab-imc-a1"
},
{
"type": "html",
"url": "https://www.sciencedirect.com/science/article/pii/S0959804915004505"
},
{
"type": "html",
"url": "https://core.ac.uk/display/82196673"
},
{
"type": "html",
"url": "https://www.ncbi.nlm.nih.gov/pubmed/26082390"
},
{
"type": "html",
"url": "https://europepmc.org/abstract/MED/26082390"
},
{
"type": "html",
"url": "https://pubmed.ncbi.nlm.nih.gov/26082390/"
},
{
"type": "unknown",
"url": "https://www.sciencedirect.com/science/article/abs/pii/S0959804915004505#!"
},
{
"type": "core_fulltext",
"url": "https://core.ac.uk/download/pdf/82196673.pdf"
}
],
"abstract": "Abstract Background Cixutumumab, a human monoclonal antibody (HuMAb), targets the insulin-like growth factor receptor...",
"references_count": 36,
"references_resolved_count": 36,
"scholarly_citations_count": 30,
"start_page": "1714",
"end_page": "1724",
"scholarly_citations": [
"000-201-187-558-654",
"003-526-658-910-015",
"003-873-121-875-383",
"007-302-126-599-214",
"010-213-946-021-323",
"013-615-059-072-408",
"013-724-699-030-436",
"014-223-693-822-29X",
"018-109-129-610-567",
"021-609-846-309-864",
"026-107-871-228-662",
"026-389-814-274-812",
"028-262-672-178-175",
"030-115-779-382-725",
"035-630-845-016-108",
"037-016-998-061-439",
"041-068-995-918-23X",
"046-312-772-821-709",
"054-371-103-868-542",
"055-935-439-115-752",
"059-021-699-657-683",
"062-343-220-167-149",
"067-043-485-486-441",
"085-619-841-835-92X",
"086-063-652-233-255",
"106-358-426-773-191",
"132-091-200-995-616",
"145-126-752-104-913",
"149-831-451-273-472",
"153-500-774-834-922"
],
"author_count": 12,
"is_open_access": true
}
],
"results": 1
}